Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (261-270 of 348) with videos related to

Pageof 35
Sort By:
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.
Journal of Virology|May 8, 2009
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceDiana M Brainard, Edward Seung, Nicole Frahm, et al.
Immunity|February 14, 2016
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Camilla Engblom, Steffen Rickelt, et al.
Gut|May 20, 2016
Tumour CD274 (PD-L1) expression and T cells in colorectal cancerYohei Masugi, Reiko Nishihara, Juhong Yang, et al.
Nature Communications|June 20, 2025
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapyXiangling Xiao, Jie Shi, Chuan He, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
Nature Communications|April 1, 2022
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapyWenjun Xiong, Xueliang Gao, Tiantian Zhang, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Haematologica|February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Pageof 35

Showing results (261-270 of 348) with videos related to

Sort By:
Pageof 35
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.
Journal of Virology|May 8, 2009
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceDiana M Brainard, Edward Seung, Nicole Frahm, et al.
Immunity|February 14, 2016
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Camilla Engblom, Steffen Rickelt, et al.
Gut|May 20, 2016
Tumour CD274 (PD-L1) expression and T cells in colorectal cancerYohei Masugi, Reiko Nishihara, Juhong Yang, et al.
Nature Communications|June 20, 2025
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapyXiangling Xiao, Jie Shi, Chuan He, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
Nature Communications|April 1, 2022
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapyWenjun Xiong, Xueliang Gao, Tiantian Zhang, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Haematologica|February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia modelDina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Pageof 35